The FDA approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (D-VRd) for patients with newly ...

A diagnosis of uveal melanoma marks the beginning of a long-term relationship with your medical team. While the focus starts with the eye, long-term care also includes regular monitoring of the liver ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

In patients with high-risk melanoma, the personalized cancer vaccine intismeran autogene and Keytruda reduced the risk of ...

A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin ...

Neoadjuvant pembrolizumab achieved a 71% pCR rate in desmoplastic melanoma, surpassing expectations for neoadjuvant anti–PD-1 treatment. The 3-year relapse-free survival rate was 74%, and the overall ...

A modest increase in image quality was observed with polarized dermatoscopes vs ambient-light dermatoscopes for patient-performed teledermoscopy.

Teddi Mellencamp has shared a sobering update on her health. On April 2, The Real Housewives of Beverly Hills alum said in an emotional Instagram video that she now has stage IV cancer. Mellencamp was ...

New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and ...

MURRAY — Intermountain Medical Center recently became one of the first medical centers in Utah to offer a genetically personalized skin cancer treatment option for those with advanced melanoma.